Literature DB >> 17698429

Role of atrial remodeling in patients with atrial fibrillation.

Li-Wei Lo1, Shih-Ann Chen.   

Abstract

Atrial fibrillation (AF) maintenance is promoted by an atrial substrate that is suitable for the initiation and continuation of the re-entering wavelets. During the first week of AF, the atrial substrate is modified by electrical remodeling, with shortening of the atrial refractoriness and slowing of the conduction velocity. Structural remodeling is the so-called "second factor" that facilitates the maintenance of AF in the following months. The ultrastructural changes result in an inhomogeneous conduction and electrical uncoupling, and the enlarged atrium is able to accommodate more circulating wave fronts that stabilize the AF. Reversal of the electrical remodeling develops within 1 week after the restoration of AF to sinus rhythm. However, reverse structural remodeling develops more slowly and may be just partially reversible. The substrate properties during AF recurrences after undergoing catheter ablation are more complex and need to be clarified in future studies.

Entities:  

Mesh:

Year:  2007        PMID: 17698429     DOI: 10.1016/S1726-4901(08)70010-8

Source DB:  PubMed          Journal:  J Chin Med Assoc        ISSN: 1726-4901            Impact factor:   2.743


  3 in total

1.  Optimum Risk Assessment for Stroke in Atrial Fibrillation: Should We Hold the Status Quo or Consider Magnitude Synergism and Left Atrial Appendage Anatomy?

Authors:  James A Reiffel
Journal:  Arrhythm Electrophysiol Rev       Date:  2017-12

2.  Electrocardiographic P wave changes after thoracoscopic pulmonary vein isolation for atrial fibrillation.

Authors:  Martina Nassif; Sébastien P J Krul; Antoine H G Driessen; Thomas Deneke; Arthur A M Wilde; Jacques M T de Bakker; Joris R de Groot
Journal:  J Interv Card Electrophysiol       Date:  2013-04-16       Impact factor: 1.900

3.  Applying harmonic optical microscopy for spatial alignment of atrial collagen fibers.

Authors:  Yu-Wei Chiu; Men Tzung Lo; Ming-Rung Tsai; Yi-Chung Chang; Rong-Bin Hsu; Hsu-Yu Yu; Chi-Kuang Sun; Yi-Lwun Ho
Journal:  PLoS One       Date:  2010-11-09       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.